跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 83,385 条关于
“SV Health Investors Fund”
全部
83,385
临床试验
65,114
药物
358
机构
1,654
资讯
16,259
10个月前
Nanopath Receives FDA Breakthrough Device Designation for Point-of-Care Molecular UTI Diagnostic Platform
去年
TRIMTECH Therapeutics Secures $31M Seed Funding for Novel Protein Degradation Platform Targeting Neurodegenerative Diseases
3个月前
Therini Bio Initiates Phase 1b Trial of Novel Anti-Inflammatory Therapy THN391 for Diabetic Macular Edema
去年
LoQus23 Therapeutics Names Industry Veteran Cyrus Mozayeni as Board Chair Following £35M Series A
去年
Therini Bio's THN391 Shows Promise in Phase 1a Trial for Neurodegenerative Diseases
去年
Dementia Discovery Fund Secures $269M in Second Fund to Accelerate Novel Therapeutics Development
3个月前
Montara Therapeutics Strengthens Leadership with Karuna Founder Andrew Miller, New CMO, and CTO Promotion to Advance Brain-Selective CNS Platform
11个月前
Harness Therapeutics Launches MISBA Duo Platform for Dual-Target Neurodegenerative Disease Treatment
去年
Therini Bio Initiates Phase 1b Trial of Novel Anti-Fibrin Antibody THN391 for Alzheimer's Disease
去年
Therini Bio Secures $39M in Series A Extension to Advance Novel Fibrin-Targeting Therapy for Neurodegenerative Diseases
第 1 页,共 1626 页
上一页
下一页